NTG-102: A Refined Molecular Therapeutic to Treat Degenerative Disc Disease

Lori Moffat, Hoda Gerami, Bettina Benigno, Ajay Matta, Mohammed Zia Karim, William Taylor, William Mark Erwin

Open source

DOI
10.21203/rs.3.rs-8419595/v1
Published
2026-03-10
Container
Not recorded
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 60/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.21203/rs.3.rs-8419595/v1,
  title = {NTG-102: A Refined Molecular Therapeutic to Treat Degenerative Disc Disease},
  author = {Lori Moffat and Hoda Gerami and Bettina Benigno and Ajay Matta and Mohammed Zia Karim and William Taylor and William Mark Erwin},
  year = {2026},
  doi = {10.21203/rs.3.rs-8419595/v1},
  url = {https://doi.org/10.21203/rs.3.rs-8419595/v1}
}

RIS

TY  - JOUR
TI  - NTG-102: A Refined Molecular Therapeutic to Treat Degenerative Disc Disease
AU  - Lori Moffat
AU  - Hoda Gerami
AU  - Bettina Benigno
AU  - Ajay Matta
AU  - Mohammed Zia Karim
AU  - William Taylor
AU  - William Mark Erwin
PY  - 2026
DO  - 10.21203/rs.3.rs-8419595/v1
UR  - https://doi.org/10.21203/rs.3.rs-8419595/v1
ER  - 

APA

Moffat, L., Gerami, H., Benigno, B., Matta, A., Karim, M. Z., Taylor, W., & Erwin, W. M. (2026). NTG-102: A Refined Molecular Therapeutic to Treat Degenerative Disc Disease. https://doi.org/10.21203/rs.3.rs-8419595/v1

Source records